- Generic name
- Methyl Prednisolone
- Strength
- 2 mg
- Dosage form
- Tablet
- Manufactured by
- Square Pharmaceuticals PLC.
Methigic 2 Tablet
About Methigic 2 Tablet
Methigic 2 is a 2 mg tablet from Square Pharmaceuticals PLC. that contains methylprednisolone, a glucocorticoid medicine. Doctors prescribe it for certain endocrine and rheumatic conditions where control of inflammation or immune activity is needed.
There are 22 brands of Methyl Prednisolone listed in Bangladesh. The lowest listed price is Depodrol 2 mg Tablet at ৳ 3 per unit.
What is Methigic 2 Tablet?
Methigic 2 is a tablet containing methylprednisolone 2 mg, made by Square Pharmaceuticals PLC. It belongs to the glucocorticoid group of medicines. Methylprednisolone is a strong anti-inflammatory medicine that also suppresses immune system activity. The written information for this medicine describes its use in some endocrine disorders, such as primary or secondary adrenocortical insufficiency, congenital adrenal hyperplasia, nonsuppurative thyroiditis, and hypercalcemia linked to cancer, and in some rheumatic disorders, such as rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, and certain kinds of bursitis, synovitis and tenosynovitis. Whether it suits a particular person depends on the doctor's assessment. The doctor decides the dose and how long it is taken.
Uses of Methigic 2
Methigic 2 is used only for conditions a doctor has diagnosed. The endocrine uses described for methylprednisolone include primary or secondary adrenocortical insufficiency, congenital adrenal hyperplasia, nonsuppurative thyroiditis, and hypercalcemia associated with cancer. Among rheumatic conditions, it is described for rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, acute and subacute bursitis, synovitis of osteoarthritis, acute nonspecific tenosynovitis, and some post-traumatic conditions. It is not a general purpose painkiller, and it should not be started for any of these problems without medical advice.
How to use Methigic 2
Take Methigic 2 exactly as your doctor tells you. The doctor sets the dose and the length of the course, and these can differ from one person to another. Swallow the tablet with water. Do not change the dose, skip days, or stop suddenly on your own, because the doctor may need to reduce it gradually. If you forget a tablet, ask your doctor or pharmacist what to do rather than guessing. Store the tablets in a cool and dry place, away from light, and keep them out of the reach of children.
Side effects of Methigic 2
Short courses of methylprednisolone are usually tolerated with few, mild side effects, while long courses at high doses may cause more serious problems. Reported effects include fluid retention, weight gain, high blood pressure, potassium loss, headache, muscle weakness, and extra hair growth. Because the risk grows with higher doses and longer use, the lowest effective dose for the shortest time is preferred, and alternate-day dosing may help reduce side effects. Tell your doctor about any side effect that worries you or does not settle.
Safety and precautions
Tell your doctor about all your health conditions and medicines before starting Methigic 2. Use is not advised in systemic fungal infections or in people known to be hypersensitive to any part of the tablet. Corticosteroids need caution in hypothyroidism, cirrhosis, and ocular herpes simplex, and aspirin should be used cautiously with them in hypoprothrombinemia. Adrenocortical insufficiency can persist for months after stopping, so hormone therapy may need to be restarted during stress. In pregnancy, it is given only if the benefit justifies the risk to the foetus, and it has not been adequately evaluated in nursing mothers. Ask your doctor first if you are pregnant, breastfeeding, or have any of these conditions.
Frequently asked questions
What does the generic name methylprednisolone mean?
Methylprednisolone is the generic name of the active substance in Methigic 2. It is a glucocorticoid, a type of corticosteroid hormone medicine that reduces inflammation and suppresses immune system activity. The brand name Methigic 2 is simply the name this company gives its 2 mg tablet of that substance.
What is Methigic 2 used for, and what kind of medicine is it?
It is a glucocorticoid tablet used for certain endocrine and rheumatic conditions that a doctor has diagnosed, such as adrenocortical insufficiency, congenital adrenal hyperplasia, some types of thyroid inflammation, high calcium linked to cancer, rheumatoid arthritis, ankylosing spondylitis, bursitis, synovitis and tenosynovitis. It is not a routine painkiller.
Who should avoid Methigic 2 or ask the doctor first?
It should not be used by people with systemic fungal infections or a known hypersensitivity to its ingredients. Ask the doctor first if you have hypothyroidism, cirrhosis, ocular herpes simplex, or low prothrombin with aspirin use, and if you are pregnant or breastfeeding. Also tell the doctor about every other medicine you take, since interactions can occur.
Can I stop Methigic 2 on my own?
No. The doctor decides the dose and course, and may need to reduce it gradually rather than stopping all at once. Stopping suddenly without advice can be unsafe, especially after longer use. If you want to stop or have missed doses, speak to your doctor or pharmacist before making any change.
Indications
Rheumatic Disorders: Rheumatoid Arthritis. Juvenile Rheumatoid Arthritis, Ankylosing ... Read moreEndocrine Disorders: Primary or Secondary Adrenocortical Insufficiency, Congenital Adrenal Hyperplasia, Nonsuppurative Thyroiditis, Hypercalcemia associated with Cancer.
Rheumatic Disorders: Rheumatoid Arthritis. Juvenile Rheumatoid Arthritis, Ankylosing Spondylitis, Acute and Subacute Bursitis, Synovitis of Osteoarthritis, Acute nonspecific Tenosynovitis, Post-traumatic Osteoarthritis, Psoriatic Arthritis, Epicondylitis, Acute Gouty Arthritis.
Collagen Diseases: Systemic lupus Erythematosus, Systemic Dermatomyositis and Acute Rheumatic Carditis.
Dermatologic Diseases: Bullous Dermatitis Herpetiformis, Severe Erythema Multiforme (Stevens-Johnson syndrome), Severe Seborrheic Dermatitis, Exfoliative Dermatitis, Mycosis Fungoides, Pemphigus, Severe Psoriasis.
Allergy: Seasonal or Perennial Allergic Rhinitis, Drug hypersensitivity reactions, Serum Sickness, Contact Dermatitis, Bronchial Asthma and Atopic Dermatitis;
Ophthalmic Diseases: Allergic Corneal Ulcers, Herpes Zoster Ophthalmicus, Anterior segment inflammation, Sympathetic Ophthalmia, Keratitis, Optic Neuritis, Allergic Conjunctivitis, Chorioretinitis, iritis end iridocyclitis.
Respiratory Diseases: Symptomatic sarcoidosis, Loeffler's syndrome not manageable by other means, berylliosis, Aspiration Pneumonitis.
Hematological Disorders: Idiopathic Thrombocytopenic Purpura in adults, Secondary Thrombocytopenia in adults, Acquired (Autoimmune) Hemolytic Anemia, Erythroblastopenia, Congenital (Erythroid) Hypoplastic Anemia.
Neoplastic Diseases: For palliative management of Leukemias and Lymphomas in adults, Acute leukemia of childhood.
Edematous States: To induce a diuresis or remission of Proteinuria in the Nephrotic Syndrome, without Uremia, of the idiopathic type or that due to Lupus Erythematosus.
Gastrointestinal Disease: To tide the patient over a critical period of the disease in Ulcerative Colitis & Regional Enteritis.
CNS Disease: Acute Exacerbations of Multiple Sclerosis.
Pharmacology
protein, and carbohydrate metabolism, skeletal muscle, the cardiovascular system, the immune system, the nervous system, and the endocrine system.
Pharmacokinetic properties: The absolute bioavailability of Methylprednisclone is generally high (82% to 89%) following oral administration and rapidly absorbed and the maximum plasma concentration is achieved around 1.5 to 2.3 hours across doses following oral administration in normal healthy adults. Methylprednisolone is widely distributed into the tissues and its volume of distribution is 41-61.5 liter. It crosses the Wood-brain barrier and the placental barrier and is secreted in breast milk. The plasma protein binding of Methylprednisolone in humans is approximately 77%. Methylprednisolone is metabolized in the liver to inactive metabolites. No dosing adjustments are necessary for renal failure. Methylprednisolone is haemodializable.
Dosage & Administration
As anti-inflammatory or immunosuppressive initial dosage: As anti-inflammatory or immunosuppressive, the initial dosage of Methylprednisolone tablets may vary from 4-48 mg per day depending on the specific disease entity being treated, in situations of less severity lower doses will generally suffice while in selected patients higher initial doses may be required. The initial dosage should be maintained or adjusted until a satisfactory response is noted. If after a reasonable period of time there is a lack of satisfactory dirtied response, Methylprednisolone should be discontinued and the patient transferred to other appropriate therapy. It should be emphasized that dosage requirements are variable and must be Individualized on the basis of the disease under treatment and the response of the patient.
As anti-inflammatory or immunosuppressive maintenance dosage: After a favorable response is noted, the proper maintenance dosage should be determined by decreasing the initial drug dosage in small decrements at appropriate time intervals until the lowest dosage which will maintain an adequate clinical response is reached. It should be kept in mind that constant monitoring is needed in regard to drug dosage. If after long-term therapy the drug is to be stopped, it is recommended that it be withdrawn gradually rather than abruptly.
Multiple Sclerosis: In the treatment of acute exacerbations of multiple sclerosis, daily doses of 160 mg of Methylprednisolone for a week followed by 64 mg every other day for 1 month have been shown to be effective.
Methylprednisolone 4 mg tablet can be used to treat and to control severe allergy end dermatitis following the guideline listed below to minimize the steroid withdrawal syndromes:
- Day 1: 2 tablets before breakfast + 1 tablet after lunch + 1 tablet after dinner + 2 tablets at bedtime
- Day 2: 1 tablet before breakfast + 1 tablet after lunch + 1 tablet after dinner + 2 tablets at bedtime
- Day 3: 1 tablet before breakfast + 1 tablet after lunch + 1 tablet after dinner + 1 tablet at bedtime
- Day 4: 1 tablet before breakfast + 1 tablet after lunch + 1 tablet at bedtime
- Day 5: 1 tablet before breakfast + 1 tablet at bedtime
- Day 6: 1 tablet before breakfast
The following should be kept in mind when considering alternate-day therapy:
- Basic principles and indications for corticosteroid therapy should be applied.
- Alternate-day therapy is a therapeutic technique primarily designed for pefienis in whom long-term pharmacologic corticoid therapy is anticipated.
- In less severe disease processes in which corticoid therapy is indicated, it may be possible to initiate treatment with alternate-day therapy. More severe disease state usually will require daily divided high dose therapy for initiai control of the disease process. The initial suppressive dose level should be continued until a satisfactory clinical response is obtained, usually four to ten days in the case of many allergic and collagen diseases.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Overdose Effects
Storage Conditions
Alternative brands of Methyl Prednisolone
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.